Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours - Concepedia

Concepedia

Publication | Open Access

Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours

DOI Full Paper Access

173

Citations

25

References

2006

Year

M. Cianfrocca, Kathryn A. Kimmel, James M. Gallo, T Cardoso, M M Brown, G. R. Hudes, Nancy Lewis, Louis M. Weiner, G N Lam, Shirley Brown,

British Journal of Cancer

References

	Year	Citations

Page 1